Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-04

Clinical Trial Update: Lumbar Spinal Fibrosis and TNF Alpha Inhibition [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating TNF-alpha inhibition for postoperative sciatica due to lumbar spinal fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Post Operative Sciatica by Lumbar Spinal Fibrosis | Phase 3 | Status: COMPLETED